247 related articles for article (PubMed ID: 34989117)
1. Greasing the inflammatory pathogenesis of viral pneumonias in diabetes.
Damen MSMA; Alarcon PC; Shah AS; Divanovic S
Obes Rev; 2022 May; 23(5):e13415. PubMed ID: 34989117
[TBL] [Abstract][Full Text] [Related]
2. Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.
Alarcon PC; Damen MSMA; Madan R; Deepe GS; Spearman P; Way SS; Divanovic S
Mucosal Immunol; 2021 Nov; 14(6):1224-1234. PubMed ID: 33958704
[TBL] [Abstract][Full Text] [Related]
3. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
4. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.
Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V
Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091
[TBL] [Abstract][Full Text] [Related]
5. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages.
Martínez-Colón GJ; Ratnasiri K; Chen H; Jiang S; Zanley E; Rustagi A; Verma R; Chen H; Andrews JR; Mertz KD; Tzankov A; Azagury D; Boyd J; Nolan GP; Schürch CM; Matter MS; Blish CA; McLaughlin TL
Sci Transl Med; 2022 Dec; 14(674):eabm9151. PubMed ID: 36137009
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
Hulme KD; Noye EC; Short KR; Labzin LI
Front Immunol; 2021; 12():770066. PubMed ID: 34777390
[TBL] [Abstract][Full Text] [Related]
8. Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies.
Abd Alhadi M; Friedman LM; Karlsson EA; Cohen-Lavi L; Burkovitz A; Schultz-Cherry S; Noah TL; Weir SS; Shulman LM; Beck MA; Hertz T
Microbiol Spectr; 2023 Jun; 11(3):e0001023. PubMed ID: 37098954
[TBL] [Abstract][Full Text] [Related]
9. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR
Front Immunol; 2020; 11():1997. PubMed ID: 32983141
[TBL] [Abstract][Full Text] [Related]
10. Immune Cell Activation in Obesity and Cardiovascular Disease.
Garcia JN; Wanjalla CN; Mashayekhi M; Hasty AH
Curr Hypertens Rep; 2022 Dec; 24(12):627-637. PubMed ID: 36136214
[TBL] [Abstract][Full Text] [Related]
11. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.
Daryabor G; Atashzar MR; Kabelitz D; Meri S; Kalantar K
Front Immunol; 2020; 11():1582. PubMed ID: 32793223
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
Mori J; Oudit GY; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
[TBL] [Abstract][Full Text] [Related]
14. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
Almerie MQ; Kerrigan DD
Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
[TBL] [Abstract][Full Text] [Related]
15. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
Huizinga GP; Singer BH; Singer K
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
[TBL] [Abstract][Full Text] [Related]
16. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.
Ramlall V; Thangaraj PM; Meydan C; Foox J; Butler D; Kim J; May B; De Freitas JK; Glicksberg BS; Mason CE; Tatonetti NP; Shapira SD
Nat Med; 2020 Oct; 26(10):1609-1615. PubMed ID: 32747830
[TBL] [Abstract][Full Text] [Related]
17. Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.
Leyfman Y; Erick TK; Reddy SS; Galwankar S; Nanayakkara PWB; Di Somma S; Sharma P; Stawicki SP; Chaudry IH
Shock; 2020 Oct; 54(4):438-450. PubMed ID: 32649367
[TBL] [Abstract][Full Text] [Related]
18. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG
Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309
[TBL] [Abstract][Full Text] [Related]
20. The Role of Adipocytes and Adipocyte-Like Cells in the Severity of COVID-19 Infections.
Kruglikov IL; Scherer PE
Obesity (Silver Spring); 2020 Jul; 28(7):1187-1190. PubMed ID: 32339391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
